Cerner Reports Fourth Quarter and Full Year 2016 Results
Feb 09, 2017 21:02 pm UTC| Business
KANSAS CITY, Mo., Feb. 09, 2017 -- Cerner Corporation (Nasdaq:CERN) today announced results for the 2016 fourth quarter and full year that ended December 31, 2016. Bookings in the fourth quarter of 2016 were $1.44...
Titan Machinery Inc. Announces Dealership Restructuring Plan
Feb 09, 2017 21:01 pm UTC| Business
- Company Expects $25 million in Annual Cost Savings from Restructuring Plan - - Consolidated Locations will be Merged into Adjacent Dealerships -- Reorganized Operating Structure Expected to Increase Efficiency and...
Ubiquiti Networks Reports Second Quarter Fiscal 2017 Financial Results
Feb 09, 2017 21:01 pm UTC| Business
~ Achieves Record Revenue ~ ~ Sixth Consecutive Quarter of Revenue Growth ~SAN JOSE, Calif., Feb. 09, 2017 -- Ubiquiti Networks, Inc. (NASDAQ:UBNT) (“Ubiquiti” or the “Company”) today announced results for the second...
RGS Energy Completes $6 Million Registered Offering of Common Stock and Warrants
Feb 09, 2017 21:01 pm UTC| Business
DENVER, Feb. 09, 2017 -- RGS Energy (NASDAQ:RGSE), a residential and small commercial solar company since 1978, has completed the previously announced $6.0 million offering of (A) units, “Primary Units,” each consisting...
Achaogen to Participate in the Leerink Partners 6th Annual Global Healthcare Conference
Feb 09, 2017 21:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Feb. 09, 2017 -- Achaogen, Inc. (NASDAQ:AKAO), a clinical-stage biopharmaceutical company developing novel antibacterials addressing multi-drug resistant (MDR) gram-negative infections,...
Valeritas Amends Existing Credit Facility to Extend Payment Obligations
Feb 09, 2017 21:01 pm UTC| Business
BRIDGEWATER, N.J., Feb. 09, 2017 -- Valeritas Holdings, Inc. (OTCQB:VLRX) today announced that it has reached an agreement with its largest lender, Capital Royalty Group (CRG), to amend its existing $50 million senior...
Immunomedics Announces Second Quarter Fiscal 2017 Results and Clinical Program Developments
Feb 09, 2017 21:00 pm UTC| Business
MORRIS PLAINS, N.J., Feb. 09, 2017 -- Immunomedics, Inc. (NASDAQ:IMMU) (“Immunomedics” or “the Company”) today reported financial results for the second quarter ended December 31, 2016. The Company also highlighted...